Clinical Trial Update: Florbetaben PET Imaging in PPA

View source ↗

Summary

A completed clinical trial evaluating Florbetaben PET imaging in patients with Primary Progressive Aphasia and Alzheimer's Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Progressive Aphasia

Drugs mentioned

• florbetaben (florbetaben)

Snippet

Sponsor: University of Chicago | Conditions: Primary Progressive Aphasia, Alzheimer Disease | Status: COMPLETED